Inducing hyperkalemia by converting enzyme inhibitors and heparin.
Durand
D
D
Service de Néphrologie, Chu Toulouse-Rangueil, France.
Ader
J L
JL
Rey
J P
JP
Tran-Van
T
T
Lloveras
J J
JJ
Bernadet
P
P
Suc
J M
JM
D000138:Acidosis / Q000150:complications; D058186:Acute Kidney Injury / Q000150:complications; D000450:Aldosterone / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005110:Extracellular Space / Q000378:metabolism; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy; D011188:Potassium / Q000097:blood
D000806:Angiotensin-Converting Enzyme Inhibitors; D000450:Aldosterone; D006493:Heparin; D011188:Potassium